Phase 2 study of two sequential three‐drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontlin... von Bensinger, William I., Jagannath, Sundar, Vescio, Robert, Camacho, Elber, Wolf, Jeffrey, Irwin, David, Capo, Gerardo, McKinley, Marti, Potts, Phyllis, Vesole, David H., Mazumder, Amitabha, Crowley, John, Becker, Pam, Hilger, Jacqueline, Durie, Brian G.M.

Volltext

Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma von Jagannath, Sundar, Durie, Brian G. M., Wolf, Jeffrey, Camacho, Elber, Irwin, David, Lutzky, Jose, McKinley, Marti, Gabayan, Eli, Mazumder, Amitabha, Schenkein, David, Crowley, John

Volltext

A phase 1b study of erlotinib in combination with gemcitabine and nab-paclitaxel in patients with previously untreated advanced pancreatic cancer: an Academic Oncology GI Cancer Co... von Cohen, Steven J., O’Neil, Bert H., Berlin, Jordan, Ames, Patricia, McKinley, Marti, Horan, Julie, Catalano, Patricia M., Davies, Angela, Weekes, Colin D., Leichman, Lawrence

Volltext

Extended follow‐up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma von Jagannath, Sundar, Durie, Brian G. M., Wolf, Jeffrey Lee, Camacho, Elber S., Irwin, David, Lutzky, Jose, McKinley, Marti, Potts, Phyllis, Gabayan, Afshin Eli, Mazumder, Amitabha, Crowley, John, Vescio, Robert

Volltext

A phase IB study of erlotinib in combination with gemcitabine and nab-paclitaxel in patients with previously untreated advanced pancreatic cancer: An Academic GI Cancer Consortium... von Leichman, Lawrence P., O'Neil, Bert H., Berlin, Jordan, Weekes, Colin D., Ames, Patricia, McKinley, Marti, Davies, Angela M., Cohen, Steven J.

Volltext

The MEK inhibitor selumetinib ([SEL], AZD6244, ARRY-142886) plus irinotecan (IRI) as second-line therapy for KRAS-mutated (KRASm) metastatic colorectal cancer (CRC) von Hochster, Howard S., Messersmith, Wells A., O'Neil, Bert H., Groshen, Susan G., Lenz, Heinz-Josef, Cohen, Deirdre Jill, Denlinger, Crystal Shereen, Gold, Philip Jordan, Eckhardt, S. Gail, Locker, Gershon Y., Ames, Patricia, McKinley, Marti, Leichman, Lawrence P.

Volltext

Second-line therapy of KRAS-mutated (KRASm) metastatic colorectal cancer (CRC) with the MEK inihibitor selumetinib ([SEL], AZ6244, ARRY-142886) in combination with irinotecan (IRI)... von Hochster, Howard S., Messersmith, Wells A., O'Neil, Bert H., Groshen, Susan G., Cohen, Deirdre Jill, Denlinger, Crystal Shereen, Gold, Philip Jordan, Eckhardt, S. Gail, Locker, Gershon Y., Ames, Patricia, McKinley, Marti, Leichman, Lawrence P.

Volltext

A Multi-Center Phase I/II Trial of Carfilzomib and Pomalidomide with Dexamethasone (Car-Pom-d) in Patients with Relapsed/Refractory Multiple Myeloma von Shah, Jatin J., Stadtmauer, Edward A., Abonour, Rafat, Cohen, Adam D, Bensinger, William I., Gasparetto, Cristina, Kaufman, Jonathan L., Lentzsch, Suzanne, Vogl, Dan T., Orlowski, Robert Z., Kim, Erica L., McKinley, Marti B., Durie, Brian G M

Volltext

A Phase II Study of Bortezomib (Velcade®), Cyclophosphamide (Cytoxan®), Thalidomide (Thalomid®) and Dexamethasone as First-Line Therapy for Multiple Myeloma von Bensinger, William, Jagannath, Sundar, Vescio, Robert, Camacho, Elber S., Wolf, Jeffrey Lee, Irwin, David H, Capo, Gerardo, McKinley, Marti, Potts, Phyllis, Vesole, David H., Mazumder, Amitabha, Esseltine, Dixie-Lee, Becker, Pamela, Crowley, John, Durie, Brian GM

Volltext

A Phase II Study of Bortezomib (Velcade®), Cylophosphamide (Cytoxan®), Thalidomide (Thalomid®) and Dexamethasone as First-Line Therapy for Multiple Myeloma von Jagannath, Sundar, Bensinger, Bill, Vescio, Robert, Camacho, Elber, Wolf, Jeffrey, Irwin, David, Capo, Gerardo, McKinley, Marti, Vesole, David H., Mazumder, Amitabha, Crowley, John, Esseltine, Dixie, Durie, Brian

Volltext

Long-Term Follow-Up of Patients Treated with Bortezomib Alone and in Combination with Dexamethasone as Frontline Therapy for Multiple Myeloma von Jagannath, Sundar, Durie, Brian G.M., Wolf, Jeffrey Lee, Camacho, Elber S., Irwin, David, Lutzky, Jose, McKinley, Marti, Gabayan, Afshin Eli, Mazumder, Amitabha, Crowley, John, Vescio, Robert

Volltext

A Phase 2 Study of Bortezomib as First-Line Therapy in Patients with Multiple Myeloma von Jagannath, Sundar, Brian, Durie, Wolf, Jeffrey L., Camacho, Elber, Irwin, David, Lutzky, Jose, McKinley, Marti, Gabayan, Eli, Mazumder, Amitabha, Crowley, John, Schenkein, David

Volltext